BONE BIOLOGICS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.91 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2020-03-30
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-03-31 was $0.91, a 52.60% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2018-03-31 was $1.92, a 2.67% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-03-31 was $1.87, a 52.66% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-03-31 was $3.95.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $0.91, a 95.25% decline from fiscal 2018.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $19.15, a 924.06% increase from fiscal 2017.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $1.87, a 3.11% decline from fiscal 2016.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $1.93, a 49.61% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.91 10-K · filed 2020-03-30 | |||
| 2019-09-30 | $0.91 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | $0.91 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | $0.91 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | $19.15 10-K · filed 2019-03-29 | |||
| 2018-09-30 | $19.15 10-Q · filed 2018-11-16 | |||
| 2018-06-30 | $19.15 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | $1.92 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | $1.87 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $1.87 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | $1.87 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | $1.87 10-Q · filed 2017-05-12 | |||
| 2016-12-31 | $1.93 10-K · filed 2018-04-02 | |||
| 2016-09-30 | $1.92 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $1.92 10-Q · filed 2016-08-15 | |||
| 2016-03-31 | $3.95 10-Q · filed 2016-05-13 | |||
| 2015-12-31 | $1.29 10-K · filed 2017-03-30 | |||
| 2015-09-30 | $1.33 10-Q · filed 2015-11-16 | |||
| 2014-12-31 | $0.73 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |